A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

Clinical trial NCT00474630 · COMPLETED

Trial details

NCT number: NCT00474630
Sponsor: Orexigen Therapeutics, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Diabetes Mellitus, Type 2

Start date: 2007-05-01
Primary completion: 2009-06-01
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.